RESEARCH PAPER |
[Download PDF] |
|
| Year : 1985 | Volume
: 17
| Issue : 2 | Page : 98--102 |
Neuroleptic therapy and antihistaminic drugs: a pharmacological study
TJ Hemnani1, SB Patel2, PG Dashputra3
1
2
3
Correspondence Address:
T J Hemnani
(1) The antipsychotic effects of chlorpromazine have been potentiated by mepyramine and pheniramine, unaffected by diphenhydramine and meclizine, while it is antagonised by promethazine.
(2) Regarding extrapyramidal effects, promethazine, diphenhydramine and mepyramine have strong antagonising effect as compared to pheniramine and meclizine.
(3) Comparison of risk-benefit ratio, suggest that during neuroleptic therapy, the prophylactic use of promethazine has harmful effect, diphenhydramine and meclizine have no effect, while mepyramine and pheniramine have a beneficial effect.
How to cite this article:
Hemnani T J, Patel S B, Dashputra P G. Neuroleptic therapy and antihistaminic drugs: a pharmacological study.Indian J Pharmacol 1985;17:98-102
|
How to cite this URL:
Hemnani T J, Patel S B, Dashputra P G. Neuroleptic therapy and antihistaminic drugs: a pharmacological study. Indian J Pharmacol [serial online] 1985 [cited 2023 Sep 27 ];17:98-102
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=1985;volume=17;issue=2;spage=98;epage=102;aulast=Hemnani;type=0 |
|
